Company Filing History:
Years Active: 2008-2012
Title: Henriette Schneider: Innovator in RNA Virus Methodology
Introduction
Henriette Schneider is a prominent inventor based in Zurich, Switzerland. She has made significant contributions to the field of virology, particularly in the development of methodologies for generating nonsegmented negative-strand RNA viruses. With a total of 4 patents, her work has implications for vaccine development and gene therapy applications.
Latest Patents
Among her latest patents is a groundbreaking invention related to cDNA corresponding to the antigenome of nonsegmented negative-strand RNA viruses. This invention outlines a methodology for generating these viruses from cloned deoxyribonucleic acid (cDNA). The rescued viruses are suitable for use as vaccines or as plasmids in somatic gene therapy applications. Additionally, her invention includes cDNA molecules that serve as tools in this methodology and helper cell lines that allow for the direct rescue of such viruses. Measles virus (MV) is utilized as a model for other representatives of the Mononegavirales, particularly the family Paramyxoviridae.
Career Highlights
Henriette Schneider has worked with notable companies such as Crucell Switzerland AG and the Swiss Serum and Vaccine Institute in Bern. Her experience in these organizations has contributed to her expertise in virology and vaccine development.
Collaborations
Some of her notable coworkers include Martin Billeter and Pius Spielhofer, who have collaborated with her on various projects in the field of virology.
Conclusion
Henriette Schneider's innovative work in the field of RNA viruses has paved the way for advancements in vaccine development and gene therapy. Her contributions continue to impact the scientific community and public health.